You X - Search Results

1

Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.

Voloshyna N, Havrdová E, Hutchinson M, Nehrych T, You X, Belachew S, Hotermans C, Paes D. Voloshyna N, et al. Among authors: you x. Eur J Neurol. 2015 Mar;22(3):570-7. doi: 10.1111/ene.12618. Epub 2014 Dec 15. Eur J Neurol. 2015. PMID: 25511792 Free PMC article.

2

Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.

Radue EW, Sprenger T, Vollmer T, Giovannoni G, Gold R, Havrdova E, Selmaj K, Stefoski D, You X, Elkins J. Radue EW, et al. Among authors: you x. Eur J Neurol. 2016 Feb;23(2):412-5. doi: 10.1111/ene.12922. Eur J Neurol. 2016. PMID: 26806217 Clinical Trial.

3

No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.

Kappos L, Havrdova E, Giovannoni G, Khatri BO, Gauthier SA, Greenberg SJ, You X, Wang P, Giannattasio G. Kappos L, et al. Among authors: you x. Mult Scler. 2017 Nov;23(13):1736-1747. doi: 10.1177/1352458516683266. Epub 2016 Dec 22. Mult Scler. 2017. PMID: 28080250 Clinical Trial.

4

Weekly IM interferon beta-1a in multiple sclerosis patients over 50 years of age.

Lampl C, You X, Limmroth V. Lampl C, et al. Among authors: you x. Eur J Neurol. 2012 Jan;19(1):142-8. doi: 10.1111/j.1468-1331.2011.03460.x. Epub 2011 Jul 1. Eur J Neurol. 2012. PMID: 21718390

5

A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.

Tolley K, Hutchinson M, You X, Wang P, Sperling B, Taneja A, Siddiqui MK, Kinter E. Tolley K, et al. Among authors: you x. PLoS One. 2015 Jun 3;10(6):e0127960. doi: 10.1371/journal.pone.0127960. eCollection 2015. PLoS One. 2015. PMID: 26039748 Free PMC article. Review.

6

Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial.

Arnold DL, Calabresi PA, Kieseier BC, Liu S, You X, Fiore D, Hung S. Arnold DL, et al. Among authors: you x. BMC Neurol. 2017 Feb 10;17(1):29. doi: 10.1186/s12883-017-0799-0. BMC Neurol. 2017. PMID: 28183276 Free PMC article. Clinical Trial.

7

Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies.

Gobbi C, Zecca C, Linnebank M, Müller S, You X, Meier R, Borter E, Traber M. Gobbi C, et al. Among authors: you x. Eur Neurol. 2013;70(1-2):35-41. doi: 10.1159/000346761. Epub 2013 May 14. Eur Neurol. 2013. PMID: 23689307 Free article.

8

Disability progression in a clinical trial of relapsing-remitting multiple sclerosis: eight-year follow-up.

Rudick RA, Lee JC, Cutter GR, Miller DM, Bourdette D, Weinstock-Guttman B, Hyde R, Zhang H, You X. Rudick RA, et al. Among authors: you x. Arch Neurol. 2010 Nov;67(11):1329-35. doi: 10.1001/archneurol.2010.150. Epub 2010 Jul 12. Arch Neurol. 2010. PMID: 20625068 Clinical Trial.

9

Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis.

Arnold DL, Calabresi PA, Kieseier BC, Sheikh SI, Deykin A, Zhu Y, Liu S, You X, Sperling B, Hung S. Arnold DL, et al. Among authors: you x. BMC Neurol. 2014 Dec 31;14:240. doi: 10.1186/s12883-014-0240-x. BMC Neurol. 2014. PMID: 25551571 Free PMC article. Clinical Trial.

10

Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.

Bermel RA, Weinstock-Guttman B, Bourdette D, Foulds P, You X, Rudick RA. Bermel RA, et al. Among authors: you x. Mult Scler. 2010 May;16(5):588-96. doi: 10.1177/1352458509360549. Epub 2010 Feb 18. Mult Scler. 2010. PMID: 20167591 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,770 results

Search Page

Filters